SCHEMBL6169812

SCHEMBL6169812

COCc1ccoc1C(=O)CCl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.40
TP53 P04637 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAPK1 P28482 2/20 0.40
ESR1 P03372 1/20 0.40
APEX1 P27695 1/20 0.40
ESR2 Q92731 1/20 0.40
ALDH1A1 P00352 3/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
THRB P10828 1/20 0.35
HTT P42858 2/20 0.33
GAA P10253 1/20 0.33
BRD4 O60885 1/20 0.33
KMT2A Q03164 1/20 0.33
GSK3B P49841 3/20 0.32
TRPA1 O75762 1/20 0.32
HIF1A Q16665 1/20 0.32
KCNA3 P22001 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7483559 0.83 TDP1 (0.40) POLBTP53TDP1L3MBTL1MAPK1
SCHEMBL11669029 0.83 TDP1 (0.42) POLBTP53TDP1L3MBTL1MAPK1
SCHEMBL21629508 0.81 TDP1 (0.43) POLBTP53TDP1L3MBTL1MAPK1
SCHEMBL18632773 0.80 ALDH1A1 (0.40) POLBTP53TDP1L3MBTL1MAPK1
Hydrochloric Acid SCHEMBL11669124 0.79 TDP1 (0.56) POLBTP53TDP1L3MBTL1MAPK1
SCHEMBL11248250 0.77 TDP1 (0.40) POLBTP53TDP1L3MBTL1MAPK1
SCHEMBL23631614 0.69 MAPT (0.40) POLBTP53TDP1L3MBTL1MAPK1
SCHEMBL6181462 0.68 GSK3B (0.36) POLBTP53MAPK1ALDH1A1MAPT
SCHEMBL3945219 0.68 TDP1 (0.55) POLBTP53TDP1L3MBTL1MAPK1
SCHEMBL6946054 0.68 ALDH1A1 (0.45) POLBTP53TDP1L3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1065206-B1 Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents PFIZER (US) 2002-10-09 EP disclosed
CN-1284064-A 2,3-substituted indole compounds as cox-2 inhibitors PFIZER PHARMA (US) 2001-02-14 CN disclosed
EP-1065206-A1 Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents PFIZER INC. (US) 2001-01-03 EP disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed